Effect of treatment with simvastatin on serum cholesteryl ester transfer in patients on dialysis

Nephrology Dialysis Transplantation

Volumn 12, Issue 1, 1997, Pages 87-92

  Walker, R J ^a   Sutherland, W H F ^b   Walker, H L ^b   MacMahon, S ^b   Robson, R A ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b NONE

Author keywords

Cholesteryl ester transfer; Dialysis; Simvastatin

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL ESTER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; SIMVASTATIN;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSLIPIDEMIA; HEMODIALYSIS; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; CHOLESTEROL ESTERS; DOUBLE-BLIND METHOD; ENZYME INHIBITORS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KIDNEY FAILURE, CHRONIC; LIPIDS; LOVASTATIN; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; RENAL DIALYSIS; SIMVASTATIN; STEROL O-ACYLTRANSFERASE;

EID: 0031030405     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/12.1.87     Document Type: Article

References (25)

1. Tall AR. Plasma cholesteryl ester transfer protein. J Lipid Res 1993; 34: 1255-1274
2. Guérin M, Dolphin PJ, Talussot C, Gardette J, Berthézène F, Chapman MJ. Pravastatin modulates cholesteryl ester transfer from HDL to ApoB-containing lipoproteins and lipoprotein subspecies profile in familial hypercholesterolemia. Arterioscler Thromb Vase Biol 1995; 15: 1359-1368
3. Bagdade JD, Lane JT, Stone N, Ritter MC, Subbaiah PV. Persistent abnormalities in lipoprotein composition and cholesteryl ester transfer following lovastatin treatment. J Lipid Res 1990; 31: 1263-1269
4. Bhatnagar D, Durrington PN, Kumar S, Mackness MI, Dean J, Boulton AJM. Effect of treatment with a hydroxymethylglutaryl Coenzyme A reductase inhibitor on fasting and postprandial plasma lipoproteins and cholesteryl ester transfer activity in patients with NIDDM. Diabetes 1995; 44: 460-465
5. Ahnadi CE, Berthézène F, Ponsin G. Simvastatin-induced decrease in the transfer of cholesterol esters from high density lipoproteins to very low density lipoproteins in normolipidemic subjects. Atherosclerosis 1993; 99: 219-228
6. Attman P-O, Alaupovic P. Lipid abnormalities in chronic renal insufficiency. Kidney Int 1991; 39 [Suppl.31]: S16-S23
7. Joven J, Vilella E, Ahmad S, Cheung MC, Brunzell JD. lipoprotein heterogeneity in end-stage renal disease. Kidney Int 1993; 43: 410-418
8. Nestel PJ, Fidge NH, Tan MH. Increased lipoprotein-remnant formation in chronic renal failure. N Engl J Med 1982; 307: 329-333
9. Corboy J, Sutherland WH, Walker RJ, Robertson MC, Cox CM. Cholesteryl ester transfer in patients with renal failure or renal transplants. Kidney Int 1994; 46: 1147-1153
10. Lopes-Virella MF, Stone P, Ellis S, Colwell JA. Cholesterol determination in high density lipoproteins separated by three different methods. Clin Chem 1977; 23: 882-884
11. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma wothout the use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502
12. Rifai N, King ME. Immunoturbidimetric assays of apolipoproteins A, AI, AII and B in serum. Clin Chem 1986; 32: 957-961
13. Channon KM, Clegg RJ, Bhatnagar D, Ishola M, Arrol S, Durrington PN. Investigation of lipid transfer in human serum leading to the development of an isotopic method for the determination of endogenous cholesterol esterification and transfer. Atherosclerosis 1990; 80: 217-226
14. Dieplinger H, Schoenfeld PY, Fielding CJ. Plasma cholesterol metabolism in end-stage renal disease. Difference between treatment by hemodialysis or peritoneal dialysis. J Clin Invest 1986; 77: 1071-1083
15. Nishizawa Y, Shoji T, Emoto M et al. Reduction of intermediate lipoprotein by pravastatin in hemo- and peritoneal dialysis patients. Clin Nephrol 1995; 43: 268-277
16. Manabe M, Abe T, Nozawa M, Maki A, Hirata M, Itakura H. New substrate for determination of serum lecithin:cholesterol acyltransferase. J Lipid Res 1987; 28: 1206-1215
17. Mann CJ, Yen FT, Grant AM, Bihain BE. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J Clin Invest 1991; 88: 2059-2066
18. Sniderman A, Cianflore K, Kwiterovich PO, Hutchinson T, Barre P, Prichard S. The major dyslipoproteinemia in patients with chronic renal failure treated with continuous ambulatory peritoneal dialysis. Atherosclerosis 1987; 65: 257-264
19. Bories PC, Subbaiah PV, Bagdade JD. Lecithin:cholesterol acyltransferase activity in dialyzed and undialyzed uremic patients. Nephron 1982; 32: 22-27
20. Sutherland WHF, Temple WA, Nye ER, Herbison PG. Lecithin: cholesterol acyltransferase activity, plasma and lipoprotein lipids and obesity in men and women. Atherosclerosis 1979; 34: 319-327
21. Schauer UJ, Schauer I. The effect of insulin and hypocaloric diet on LCAT activity in type 2 diabetes. International Symposium on The Lipid Triad (Triglycerides, HDL, LDL) and Cardiovascular Diseases (abstract) 1993, 56
22. Avram MM, Goldwasser P, Burrell DE, Antinani A, Fein PA, Mittman N. The uremic dyslipidemia: A cross-sectional and longitudinal study. Am J Kidney Dis 1992; 20: 324-335
23. Bhatnagar D, Durrington PN, Channon KM, Prais H, Mackness MI. Increased transfer of cholesteryl esters from high density lipoproteins to low density and very low density lipoproteins in patients with angiographic evidence of coronary artery disease. Atherosclerosis 1993; 98: 25-32
24. Oram JF, Albers JJ, Cheung MC, Bierman EL. The effects subfractions of high density lipoprotein on cholesterol efflux from cultured fibroblasts. J Biol Chem 1981; 256: 8348-8356
25. Sutherland WHF, Corboy J, Walker RJ, Robertson MC, Ball MJ. Cell cholesterol transport to plasma in blood from patients with renal failure or a kidney transplant. Nephrol Dial Transplant 1995; 10: 358-365